• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素受体作为人眼葡萄膜黑色素瘤的分子靶点。

Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.

机构信息

Department of Biopharmacy, University of Debrecen, 4032 Debrecen, Hungary.

Department of Pathology, University of Debrecen, 4032 Debrecen, Hungary.

出版信息

Molecules. 2018 Jun 26;23(7):1535. doi: 10.3390/molecules23071535.

DOI:10.3390/molecules23071535
PMID:29949880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6100349/
Abstract

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, with an incidence of 4⁻5 cases per million. The prognosis of UM is very poor. In the present study, our aim was to investigate the expression of mRNA and protein for somatostatin receptor types-1, -2, -3, -4, -5 (SSTR-1⁻5) in human UM tissue samples and in OCM-1 and OCM-3 human UM cell lines by qRT-PCR, western blot and ligand competition assay. The mRNA for SSTR-2 showed markedly higher expression in UM tissues than SSTR-5. The presence of SSTRs was demonstrated in 70% of UM specimens using ligand competition assay and both human UM models displayed specific high affinity SSTRs. Among the five SSTRs, the mRNA investigated for SSTR-2 and SSTR-5 receptors was strongly expressed in both human UM cell lines, SSTR-5 showing the highest expression. The presence of the SSTR-2 and SSTR-5 receptor proteins was confirmed in both cell lines by western blot. In summary, the expression of somatostatin receptors in human UM specimens and in OCM-1 and OCM-3 human UM cell lines suggests that they could serve as a potential molecular target for therapy of UM using modern powerful cytotoxic SST analogs targeting SSTR-2 and SSTR-5 receptors.

摘要

葡萄膜黑色素瘤 (UM) 是成年人中最常见的原发性眼内恶性肿瘤,发病率为每百万 4⁻5 例。UM 的预后非常差。在本研究中,我们旨在通过 qRT-PCR、western blot 和配体竞争分析,研究 somatostatin 受体类型-1、-2、-3、-4、-5(SSTR-1⁻5)在人 UM 组织样本和 OCM-1 和 OCM-3 人 UM 细胞系中的 mRNA 和蛋白表达。与 SSTR-5 相比,SSTR-2 在 UM 组织中的 mRNA 表达明显更高。通过配体竞争分析,在 70%的 UM 标本中证实了 SSTRs 的存在,两种人 UM 模型均显示出特异性高亲和力 SSTRs。在这五个 SSTR 中,研究的 SSTR-2 和 SSTR-5 受体 mRNA 在两种人 UM 细胞系中均强烈表达,SSTR-5 表达最高。western blot 证实了两种细胞系中 SSTR-2 和 SSTR-5 受体蛋白的存在。总之,人 UM 标本和 OCM-1 和 OCM-3 人 UM 细胞系中 somatostatin 受体的表达表明,它们可能成为使用针对 SSTR-2 和 SSTR-5 受体的现代强大细胞毒性 SST 类似物治疗 UM 的潜在分子靶标。

相似文献

1
Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.生长抑素受体作为人眼葡萄膜黑色素瘤的分子靶点。
Molecules. 2018 Jun 26;23(7):1535. doi: 10.3390/molecules23071535.
2
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.将促黄体生成素释放激素I型受体(LH-RH-I)鉴定为OCM-1和OCM-3人葡萄膜黑色素瘤细胞系中的潜在分子靶点。
Onco Targets Ther. 2018 Feb 22;11:933-941. doi: 10.2147/OTT.S148174. eCollection 2018.
3
Expression of the metastasis suppressor gene KISS1 in uveal melanoma.转移抑制基因KISS1在葡萄膜黑色素瘤中的表达
Eye (Lond). 2008 May;22(5):707-11. doi: 10.1038/sj.eye.6703090. Epub 2008 Jan 25.
4
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).用靶向细胞毒黄体生成素释放激素类似物(AN-152)治疗多柔比星耐药的人葡萄膜黑色素瘤的实验治疗。
Eur J Pharm Sci. 2018 Oct 15;123:371-376. doi: 10.1016/j.ejps.2018.08.002. Epub 2018 Aug 2.
5
Differential expression of Mart-1 in human uveal melanoma cells.人葡萄膜黑色素瘤细胞中 Mart-1 的差异表达。
Mol Med Rep. 2011 Sep-Oct;4(5):799-803. doi: 10.3892/mmr.2011.504. Epub 2011 Jun 7.
6
Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.转移性脉络膜黑色素瘤患者的生长抑素受体闪烁显像。
Melanoma Res. 2013 Feb;23(1):33-9. doi: 10.1097/CMR.0b013e32835b70e9.
7
Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.慢病毒介导 VP22-CD/5-FC 自杀基因系统对小鼠葡萄膜黑色素瘤的抗肿瘤作用。
Exp Eye Res. 2018 Jul;172:144-151. doi: 10.1016/j.exer.2018.04.009. Epub 2018 Apr 13.
8
Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.源自一条3号染色体缺失肿瘤的两种葡萄膜黑色素瘤细胞系的建立与鉴定
Exp Eye Res. 2006 Oct;83(4):858-64. doi: 10.1016/j.exer.2006.04.004. Epub 2006 Jun 5.
9
Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.葡萄膜黑色素瘤中生长抑素受体2的表达并非预后标志物。
Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1585-92. doi: 10.1007/s00417-008-0880-x. Epub 2008 Aug 6.
10
Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders.生长抑素受体亚型(SSTR-1-SSTR-5)在儿科血液和肿瘤疾病中的表达。
Molecules. 2020 Dec 7;25(23):5775. doi: 10.3390/molecules25235775.

引用本文的文献

1
Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias.生长抑素的激动剂、拮抗剂与受体:在肿瘤中的病理生理学及治疗意义
Curr Issues Mol Biol. 2024 Sep 2;46(9):9721-9759. doi: 10.3390/cimb46090578.
2
Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach.作为癌症生物标志物的 G 蛋白偶联受体生长抑素受体 2 和 3 的表达流行率和动态变化:一种配对免疫组织化学方法。
Sci Rep. 2023 Nov 27;13(1):20857. doi: 10.1038/s41598-023-47877-0.
3
Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review.

本文引用的文献

1
Pasireotide in the treatment of neuroendocrine tumors: a review of the literature.培高利特治疗神经内分泌肿瘤:文献复习。
Endocr Relat Cancer. 2018 Jun;25(6):R351-R364. doi: 10.1530/ERC-18-0010. Epub 2018 Apr 11.
2
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.将促黄体生成素释放激素I型受体(LH-RH-I)鉴定为OCM-1和OCM-3人葡萄膜黑色素瘤细胞系中的潜在分子靶点。
Onco Targets Ther. 2018 Feb 22;11:933-941. doi: 10.2147/OTT.S148174. eCollection 2018.
3
The biology of uveal melanoma.
多种肿瘤中生长抑素受体的综合评估:一项系统综述
Pharmaceutics. 2022 Jul 1;14(7):1394. doi: 10.3390/pharmaceutics14071394.
4
Neuroendocrine Factors in Melanoma Pathogenesis.黑色素瘤发病机制中的神经内分泌因素
Cancers (Basel). 2021 May 10;13(9):2277. doi: 10.3390/cancers13092277.
5
Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders.生长抑素受体亚型(SSTR-1-SSTR-5)在儿科血液和肿瘤疾病中的表达。
Molecules. 2020 Dec 7;25(23):5775. doi: 10.3390/molecules25235775.
葡萄膜黑色素瘤的生物学
Cancer Metastasis Rev. 2017 Mar;36(1):109-140. doi: 10.1007/s10555-017-9663-3.
4
Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma.葡萄膜黑色素瘤的肿瘤特征、遗传学、治疗及转移风险
Semin Ophthalmol. 2016;31(4):304-9. doi: 10.3109/08820538.2016.1154175. Epub 2016 Apr 29.
5
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.转移性葡萄膜黑色素瘤的系统治疗:文献回顾与未来展望。
Cancer Med. 2013 Oct;2(5):674-86. doi: 10.1002/cam4.133. Epub 2013 Sep 18.
6
Proteomics of uveal melanoma: a minireview.葡萄膜黑色素瘤的蛋白质组学:一篇综述。
J Oncol. 2013;2013:820953. doi: 10.1155/2013/820953. Epub 2013 Sep 3.
7
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.促黄体生成素释放激素(LHRH)I型受体在人葡萄膜黑色素瘤中的大量表达。
Oncotarget. 2013 Oct;4(10):1721-8. doi: 10.18632/oncotarget.1379.
8
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].通过新型细胞毒生长抑素类似物 AN-162 [AEZS-124] 靶向三阴性乳腺癌的生长抑素受体。
Anticancer Drugs. 2013 Feb;24(2):150-7. doi: 10.1097/CAD.0b013e32835a7e29.
9
Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression.生长抑素、生长抑素类似物和生长抑素受体在癌症进展生物学中的动态变化。
Curr Mol Med. 2013 May;13(4):555-71. doi: 10.2174/1566524011313040008.
10
Uveal melanoma: trends in incidence, treatment, and survival.葡萄膜黑色素瘤:发病趋势、治疗方法和生存率。
Ophthalmology. 2011 Sep;118(9):1881-5. doi: 10.1016/j.ophtha.2011.01.040. Epub 2011 Jun 24.